• FMC entered a co-exclusive supply and license agreement with Corteva for rimisoxafen herbicide technology in North and South American corn, soybean markets.
• FMC will supply the active ingredient, retain ownership rights, while each company develops and sells its own exclusive premix formulations.
• Corteva will make an initial prepurchase payment of USD 200 million for product supplied by FMC.
• First commercial sales expected by end of the decade, subject to regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: PH85225) on June 16, 2026, and is solely responsible for the information contained therein.